| Protocol No. | Title | Status |
| 08-0311-02 | Knowledge Integration in Quitlines: Networks that Improve Cessation | Open |
| 09-1104-10 | S0819 A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Advanced Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Non-Small Cell Lung Cancer (NSCLC)." | Open |
| 11-0530-10 | E1505: A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (> 4 cm) - lll A Non-Small Cell Lung Cancer (NSCLC) | Open |
| 12-0557-04 | A Randomized, Double-Blind, Phase 2, Dose-Ranging Study to Evaluate the Safety and Efficacy of Veliparib and Whole Brain Radiation Therapy Versus Placebo and Whole Brain Radiation Therapy in Subjects with Brain Metastases from Non-Small Cell Lung Cancer (M10-897) | Open |
| 20110329 | Phase I Dose Escalation Study of Everolimus, Pemetrexed,
Carboplatin, and Bevacizumab in Stage IV Non-Squamous Non-
Small Cell Lung Cancer | Open |
| 20111757 | A Phase 1/2 Study to Assess the Safety and Efficacy of LorvotuzumabMertansine (IMGN901) in Combination with Carboplatin/Etoposide inPatients with Advanced Solid Tumors including Extensive Stage Small Cell Lung Cancer (Phase 2 only) | Open |
| 20121569 | PROTOCOL EC-FV-07: A RANDOMIZED, OPEN-LABEL PHASE 2 STUDY OF EC145 SINGLE-AGENT AND THE COMBINATION OF EC145 PLUS DOCETAXEL VERSUS DOCETAXEL ALONE IN PARTICIPANTS WITH FOLATE-RECEPTOR POSITIVE [FR(++)] SECOND LINE NSCLC | Open |